These novel medications , including Semaglutide , Tirzepatide , and Zaxig , represent a important advancement in addressing type 2 the condition and promoting weight management. They operate by mimicking the body’s natural incretin GLP-1 , enabling to moderate blood glucose and reduce appetite . Every medication has slightly unique qualities and